A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT)
- DOI
- 10.1186/s12885-023-11430-z
- Published
- 2023-09-30
- Container
- BMC Cancer
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12885-023-11430-z,
title = {A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT)},
author = {Sydney Wolfe and Marshall A. Diven and Ariel E. Marciscano and Xi Kathy Zhou and A. U. Kishan and M. L. Steinberg and Joseph A. Miccio and Philip Camilleri and Himanshu Nagar},
year = {2023},
journal = {BMC Cancer},
doi = {10.1186/s12885-023-11430-z},
url = {https://doi.org/10.1186/s12885-023-11430-z}
}RIS
TY - JOUR TI - A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT) AU - Sydney Wolfe AU - Marshall A. Diven AU - Ariel E. Marciscano AU - Xi Kathy Zhou AU - A. U. Kishan AU - M. L. Steinberg AU - Joseph A. Miccio AU - Philip Camilleri AU - Himanshu Nagar PY - 2023 JO - BMC Cancer DO - 10.1186/s12885-023-11430-z UR - https://doi.org/10.1186/s12885-023-11430-z ER -
APA
Wolfe, S., Diven, M. A., Marciscano, A. E., Zhou, X. K., Kishan, A. U., Steinberg, M. L., Miccio, J. A., Camilleri, P., & Nagar, H. (2023). A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT). BMC Cancer. https://doi.org/10.1186/s12885-023-11430-z
Source records
- crossref · retrieved 2026-09-27T05:11:17.527Z